Skip to main content
. 2016 May 10;10(5):e0004707. doi: 10.1371/journal.pntd.0004707

Table 1. Deworming activities through different platforms in Burkina Faso.

Population groups Treatment drugs Treatment frequency Period MDA platform Notes
Pre-school age children (12–59 months) Mebendazole Twice a year Since 2007 Vitamin A supplementation Door-to-door distribution during Child Health Days that include vitamin A supplementation
School age children (5–14 years) Albendazole Once every two years 2004–2006 Schistosomiasis MDA (school- and community-based) Albendazole treatment with praziquantel stopped after integration with LF MDA.
Total LF eligible population (≥5 years old) Albendazole + ivermectin Once a year (twice a year in 4 districts in Sud Ouest region) Since 2001 LF MDA (community-based) Geographical coverage was gradually scaled up to 100% in 2005, and then has been gradually scaled down since 2012.